Relationship between nm23-H1 levels and clinicopathologic factors
| Clinical factor . | No. of patients . | nm23-H1 Level (ng/mL) (mean ± SD) . | P value . |
|---|---|---|---|
| Age (y) | |||
| <60 | 56 | 62.5 ± 35.4 | .7951 |
| ≧60 | 44 | 60.8 ± 33.9 | |
| Gender | |||
| Male | 50 | 63.3 ± 40.0 | .6707 |
| Female | 52 | 80.4 ± 26.8 | |
| WBC count (/μL) | |||
| ≦10,000 | 55 | 52.2 ± 32.0 | .0001 |
| >10,000, ≦50,000 | 35 | 62.2 ± 28.6 | |
| >50,000 | 12 | 104.6 ± 31.1 | |
| Increased LDH (≧5× normal) | |||
| No | 90 | 55.2 ± 28.1 | .0004 |
| Yes | 12 | 111.5 ± 39.5 | |
| Chromosomal aberration | |||
| Good | 27 | 50.4 ± 25.5 | .1076 |
| Intermediate | 50 | 63.5 ± 37.7 | |
| Poor | 22 | 73.2 ± 34.5 | |
| Response | |||
| Complete remission | 69 | 40.1 ± 19.7 | .0001 |
| Nonresponse | 33 | 94.7 ± 36.1 |
| Clinical factor . | No. of patients . | nm23-H1 Level (ng/mL) (mean ± SD) . | P value . |
|---|---|---|---|
| Age (y) | |||
| <60 | 56 | 62.5 ± 35.4 | .7951 |
| ≧60 | 44 | 60.8 ± 33.9 | |
| Gender | |||
| Male | 50 | 63.3 ± 40.0 | .6707 |
| Female | 52 | 80.4 ± 26.8 | |
| WBC count (/μL) | |||
| ≦10,000 | 55 | 52.2 ± 32.0 | .0001 |
| >10,000, ≦50,000 | 35 | 62.2 ± 28.6 | |
| >50,000 | 12 | 104.6 ± 31.1 | |
| Increased LDH (≧5× normal) | |||
| No | 90 | 55.2 ± 28.1 | .0004 |
| Yes | 12 | 111.5 ± 39.5 | |
| Chromosomal aberration | |||
| Good | 27 | 50.4 ± 25.5 | .1076 |
| Intermediate | 50 | 63.5 ± 37.7 | |
| Poor | 22 | 73.2 ± 34.5 | |
| Response | |||
| Complete remission | 69 | 40.1 ± 19.7 | .0001 |
| Nonresponse | 33 | 94.7 ± 36.1 |
WBC indicates white blood cell; LDH, lactic dehydrogenase.